Tenaya Therapeutics, Inc.
TNYA
$0.72
$0.011.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.06% | -15.35% | -22.35% | -23.41% | -20.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.55% | -19.51% | -20.80% | -18.88% | -16.39% |
| Operating Income | 21.75% | 19.51% | 20.80% | 18.88% | 16.39% |
| Income Before Tax | 21.52% | 18.48% | 19.59% | 17.49% | 15.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.52% | 18.48% | 19.59% | 17.49% | 15.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.52% | 18.48% | 19.59% | 17.49% | 15.10% |
| EBIT | 21.75% | 19.51% | 20.80% | 18.88% | 16.39% |
| EBITDA | 22.26% | 21.01% | 22.48% | 20.51% | 17.77% |
| EPS Basic | 59.42% | 52.32% | 45.42% | 37.59% | 29.60% |
| Normalized Basic EPS | 59.42% | 52.31% | 45.41% | 37.59% | 29.61% |
| EPS Diluted | 59.42% | 52.32% | 45.42% | 37.59% | 29.60% |
| Normalized Diluted EPS | 59.42% | 52.31% | 45.41% | 37.59% | 29.61% |
| Average Basic Shares Outstanding | 95.05% | 80.12% | 59.78% | 41.47% | 21.74% |
| Average Diluted Shares Outstanding | 95.05% | 80.12% | 59.78% | 41.47% | 21.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |